Crossmark

Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease

Crossref DOI link: https://doi.org/10.1038/s41409-018-0163-z

Published Online: 2018-04-18

Published Print: 2018-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Perez, Lia

Fernandez, Hugo

Horna, Pedro

Riches, Marcie https://orcid.org/0000-0003-0257-0990
Locke, Frederick

Field, Teresa

Powers, John

Sahakian, Eva

Villagra, Alejandro

Mishra, Asmita

Betts, Brian https://orcid.org/0000-0001-7643-2422
Kharfan-Dabaja, Mohamed

Beato, Francisca

Ochoa-Bayona, Leonel

Pidala, Joseph

Anasetti, Claudio
License Information

Text and Data Mining valid from 2018-04-18
More Information

Article History

Received: 16 November 2017

Revised: 5 February 2018

Accepted: 25 February 2018

First Online: 18 April 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.